As research continues, the list of potential applications grows, suggesting these medications may eventually be viewed less as weight loss drugs and more as metabolic health optimizers with wide-ranging benefits
Jensen SBK, Srensen V, Sandsdal RM, et al
While earlier GLP-1 drugs have decades of data behind them, newer high-potency agonists and multi-agonist combinations will require extended monitoring as their use expands
and all-cause mortality
Weight loss medications affect digestion, blood sugar, hydration, kidney function, gallbladder risk, and overall metabolism
This can reduce the reinforcing effects of food and certain addictive behaviors, which is why some people report reduced food noise or fewer cravings